Patients with moderate-to-severe plaque psoriasis who took the once-daily pill showed significantly clearer skin compared with those on placebo or the existing therapy apremilast, the company said.

During the year the industry saw continued consolidation, the end of a key advisory body, the rise in DTC testing and advanced diagnostics, and another stab at PAMA reform.

NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical ...

The Trump administration is about to give artificial intelligence a formal say in who gets certain Medicare services, starting with a pilot in six states that will run through private contractors. The ...

The FDA has granted 510(k) clearance to a Bay Area medical technology firm for its proprietary delirium monitoring solution, ...

AI agents are becoming algorithmic customers and redefining holiday shopping, supply chains and trust while raising new ...

Third is adaptive leadership development that treats change as the new steady state. Organizations achieving successful large ...

Cui, J.X., Liu, K.H. and Liang, X.J. (2026) A Brief Discussion on the Theory and Application of Artificial Intelligence in ...

TrivarX (ASX: TRI) has delivered positive results from a US-based clinical trial that demonstrate clinically meaningful, ...